These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29486427)

  • 1. Pharmacogenetics and target identification in diabetes.
    Pearson ER
    Curr Opin Genet Dev; 2018 Jun; 50():68-73. PubMed ID: 29486427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monogenic Forms of Diabetes Mellitus.
    Gaál Z; Balogh I
    Exp Suppl; 2019; 111():385-416. PubMed ID: 31588541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic causes and treatment of neonatal diabetes and early childhood diabetes.
    Barbetti F; D'Annunzio G
    Best Pract Res Clin Endocrinol Metab; 2018 Aug; 32(4):575-591. PubMed ID: 30086875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monogenic models: what have the single gene disorders taught us?
    Klupa T; Skupien J; Malecki MT
    Curr Diab Rep; 2012 Dec; 12(6):659-66. PubMed ID: 22996131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
    Garcin L; Mericq V; Fauret-Amsellem AL; Cave H; Polak M; Beltrand J
    Pediatr Diabetes; 2020 Sep; 21(6):932-941. PubMed ID: 32418263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
    Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
    Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
    Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of type 2 diabetes mellitus and other specific types of diabetes; its role in treatment modalities.
    Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
    Diabetes Metab Syndr; 2012; 6(1):54-8. PubMed ID: 23014256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic Diabetes: Not Your "Typical" Diabetes.
    Wiley F
    Diabetes Self Manag; 2016; 33(4):36-7. PubMed ID: 27491106
    [No Abstract]   [Full Text] [Related]  

  • 12. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.
    Javorsky M; Klimcakova L; Schroner Z; Zidzik J; Babjakova E; Fabianova M; Kozarova M; Tkacova R; Salagovic J; Tkac I
    Eur J Intern Med; 2012 Apr; 23(3):245-9. PubMed ID: 22385882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.
    Hartemann-Heurtier A; Simon A; Bellanné-Chantelot C; Reynaud R; Cavé H; Polak M; Vaxillaire M; Grimaldi A
    Diabetes Metab; 2009 Jun; 35(3):233-5. PubMed ID: 19342262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.
    Katanic D; Vorgučin I; Hattersley A; Ellard S; Houghton JAL; Obreht D; Knežević Pogančev M; Vlaški J; Pavkov D
    Diabetes Res Clin Pract; 2017 Jul; 129():59-61. PubMed ID: 28511139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.
    Zhou K; Pedersen HK; Dawed AY; Pearson ER
    Nat Rev Endocrinol; 2016 Jun; 12(6):337-46. PubMed ID: 27062931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D
    Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
    Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.
    Klen J; Dolžan V; Janež A
    Eur J Clin Pharmacol; 2014 Apr; 70(4):421-8. PubMed ID: 24442125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in diabetes genetics].
    Njølstad PR; Hertel JK; Søvik O; Raeder H; Johansson S; Molven A
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1145-9. PubMed ID: 20531501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.